1242239

Sumitomo Pharma America, Inc. — FEI 1222021

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 2, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Marlborough, MA (United States)

Additional Details

Sponsor, Contract Research Organization